Objectives: To perform a Bayesian reanalysis of a recent trial of psilocybin (COMP360) versus escitalopram for Major Depressive Disorder (MDD) in order to provide a more informative interpretation of the indeterminate outcome of a previous frequentist analysis.
Design: Reanalysis of a two-arm double-blind placebo controlled trial.
Participants: Fifty-nine patients with MDD.
Interventions: Two doses of psilocybin 25mg and daily oral placebo versus daily escitalopram and 2 doses of psilocybin 1mg, with psychological support for both groups.
Outcome Measures: Quick Inventory of Depressive Symptomatology-Self-Report (QIDS SR-16), and three other depression scales as secondary outcomes: HAMD-17, MADRS, and BDI-1A.
Results: Using Bayes factors and 'skeptical priors' which bias estimates towards zero, for the hypothesis that psilocybin is superior by any margin, we found indeterminate evidence for QIDS SR-16, strong evidence for BDI-1A and MADRS, and extremely strong evidence for HAMD-17. For the stronger hypothesis that psilocybin is superior by a 'clinically meaningful amount' (using literature defined values of the minimally clinically important difference), we found moderate evidence against it for QIDS SR-16, indeterminate evidence for BDI-1A and MADRS, and moderate evidence supporting it for HAMD-17. Furthermore, across the board we found extremely strong evidence for psilocybin's non-inferiority versus escitalopram. These findings were robust to prior sensitivity analysis.
Conclusions: This Bayesian reanalysis supports the following inferences: 1) that psilocybin did indeed outperform escitalopram in this trial, but not to an extent that was clinically meaningful--and 2) that psilocybin is almost certainly non-inferior to escitalopram. The present results provide a more precise and nuanced interpretation to previously reported results from this trial, and support the need for further research into the relative efficacy of psilocybin therapy for depression with respect to current leading treatments.
Trial Registration Number: NCT03429075.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278160 | PMC |
| http://dx.doi.org/10.1089/psymed.2022.0002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Conscious Side of 'Subliminal' Linguistic Priming: A Systematic Review With Meta-Analysis and Reliability Analysis of Visibility Measures.
J Cogn
January 2025
Departamento de Psicología Básica, Facultad de Psicología, Universidad Autónoma de Madrid, Spain.
Research on unconscious processing has been a valuable source of evidence in psycholinguistics for shedding light on the cognitive architecture of language. The automaticity of syntactic processing, in particular, has long been debated. One strategy to establish this automaticity involves detecting significant syntactic priming effects in tasks that limit conscious awareness of the stimuli.
View Article and Find Full Text PDFDownscaling of ERA5 reanalysis land surface temperature based on attention mechanism and Google Earth Engine.
Sci Rep
January 2025
Aerospace Information Research Institute, Chinese Academy of Sciences, Beijing, 100094, China.
Land Surface Temperature (LST) is widely recognized as a sensitive indicator of climate change, and it plays a significant role in ecological research. The ERA5-Land LST dataset, developed and managed by the European Centre for Medium-Range Weather Forecasts (ECMWF), is extensively used for global or regional LST studies. However, its fine-scale application is limited by its low spatial resolution.
View Article and Find Full Text PDFBayesian Reanalysis of Statistically Nonsignificant Outcomes in Plastic Surgery Clinical Trials.
Plast Reconstr Surg Glob Open
December 2024
From the Section of Plastic Surgery, Department of Surgery, University of Michigan Medical School, Ann Arbor, MI.
Background: Statistically nonsignificant randomized clinical trial (RCT) results are challenging to interpret, as they are unable to prove the absence of a difference between treatment groups. Bayesian analysis offers an alternative statistical framework capable of providing a comprehensive understanding of nonsignificant results.
Methods: This cross-sectional study conducted a post hoc Bayesian analysis of statistically nonsignificant outcomes from RCTs published in from 2013 to 2022.
Critical care nutrition: a Bayesian re-analysis of trial data.
Curr Opin Clin Nutr Metab Care
November 2024
Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto.
Article Synopsis
- Nutritional support and glucose control are crucial in critical illness care, but current evidence is inconsistent, making it hard to apply findings clinically.
- The review highlights how Bayesian methods can help clarify the mixed outcomes from recent critical care trials (NUTRIREA-3, EFFORT Protein, TGC-Fast) by providing more interpretable results.
- By re-analyzing mortality data through a Bayesian lens, the study shows these methods can identify benefits and risks more effectively than traditional frequentist approaches, potentially improving clinical decision-making.
The association between ozone exposure and blood pressure in a general Chinese middle-aged and older population: a large-scale repeated-measurement study.
BMC Med
November 2024
State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, National Innovation Platform for Industry-Education Integration in Vaccine Research, Xiamen University, Xiamen, Fujian, China.
Background: The relationship between ozone (O) exposure and blood pressure (BP) remains inconclusive. Given the scarcity of Chinese epidemiological data, more research on this association is of paramount importance, particularly among middle-aged and older Chinese populations.
Methods: This study involved 10,875 participants (median age: 60.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!